BioSpace News Archive

Neonode Inc., (NASDAQ: NEON), the optical sensing technology company, today announced that its zForce® Touch Solutions are now optimized for reducing pathogen transmission in hospitals and other public spaces, by enabling contact-free interaction with graphical user interface (GUIs).

Sensera Limited (ASX: SE1, “Sensera” or “the Company”), is pleased to announce that its subsidiary Sensera Inc. (MicroDevices), a designer and manufacturer of high-performance sensors and modules, has expanded its capabilities to include precision fibre optic assemblies

The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President of the European Investment Bank (EIB), during his visit to BiondVax’s new mid-size commercial scale manufacturing facility in Israel.

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the top pharmaceutical supply chain challenges in 2019.

Regulations will require hospitals to report serious adverse drug reactions and medical device incidents to Health Canada

The Healthcare Financial Management Association (HFMA) yesterday presented Kenneth Kaufman, co-founder and chair of Kaufman Hall, with its highest individual achievement recognition, the Richard L. Clarke Board of Directors Award.

Today, Governor John Bel Edwards joined Secretary Rebekah Gee of the Louisiana Department of Health, Secretary James LeBlanc of the Louisiana Department of Corrections, and Asegua Therapeutics LLC, a wholly-owned subsidiary of Gilead Sciences, Inc. (Nasdaq: GILD), to announce a deal that will allow the implementation of an innovative payment model for hepatitis C treatment, part of Louisiana’s plan to eliminate the disease.

Award by National Association for Business Resources recognizes innovative organizations that are leading their industries and contributing to society

SAFFORIA, the first all-natural saffron elixir debuts the launch of its inaugural Euphoric Detoxifier, Gold Rush, in a 4 oz. shot.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the second quarter of 2019 on August 5, 2019 after the close of the financial markets